BBE-21815-51127
3 vaccinations
5 coded responses
30 check-ins
5 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 181 / PA
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
HPY-19974-91741
Child or adolescent in my care · Female · 2022-06-28
Timeline
-
2021-01-10
Registered in v-safe
-
2021-01-10
Dose 1 — Moderna
- 2021-01-10
-
2021-01-11
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessFree text: Injection site pain started 6 hrs post; other symptoms started 28 hrs post.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Survey response — days 1–6 daily, dose 1MedDRA: Chills, Fatigue, Injection site pain, Pain, Palpitations — Feeling: Good · Site: PainFree text: Chills, aches, and fatigue resolved by Tuesday morning; pain at injection site also started improving yesterday and today is only evident on palpation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
- 2021-01-16
- 2021-01-17
- 2021-01-24
- 2021-01-31
-
2021-02-07
Dose 2 — Moderna
- 2021-02-07
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-13
- 2021-02-14
- 2021-02-21
- 2021-03-01
- 2021-03-07
- 2021-03-14
- 2021-03-21
-
2021-05-09
Survey response — 3 months, dose 2MedDRA: Cellulitis, Dermatitis contact — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Severe poison ivy rash with secondary cellulitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-09
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-09
-
2021-10-22
Dose 3 — ModernaCo-administered: Flu
-
2021-10-26
Survey response — days 1–6 daily, dose 3MedDRA: Chills, Injection site pain, Malaise, Pain — Feeling: GoodFree text: Soreness at the injection site began 1-2 hours after administration and subsided after 36-48 hours; experienced minor chills, aches, and malaise the day after administration.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-06
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-05
-
2022-01-23
Survey response — 3 months, dose 3MedDRA: Dry eye, Ocular hyperaemia — Feeling: GoodFree text: Acute-onset redness of my corneas (left worse than right) and drier eyes. Left eye 4-5 days duration; right eye 2-3 days.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-23
- 2022-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-10 | Moderna | |
| 2 | 2021-02-07 | Moderna | |
| 3 | 2021-10-22 | Moderna | Flu |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Injection site pain started 6 hrs post; other symptoms started 28 hrs post.
Systemic reaction (other): Chills, aches, and fatigue resolved by Tuesday morning; pain at injection site also started improving yesterday and today is only evident on palpation.
Release 8 — 3 months, dose 2
Symptoms: Severe poison ivy rash with secondary cellulitis
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Soreness at the injection site began 1-2 hours after administration and subsided after 36-48 hours; experienced minor chills, aches, and malaise the day after administration.
Release 11 — 3 months, dose 3
Symptoms: Acute-onset redness of my corneas (left worse than right) and drier eyes. Left eye 4-5 days duration; right eye 2-3 days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cellulitis | ✓ | ✓ | ✓ |
| SD | Dermatitis contact | ✓ | ✓ | ✓ |
| SD | Dry eye | · | · | ✓ |
| SD | Ocular hyperaemia | · | · | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Malaise | · | · | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release